Relationship between Serum Gamma-glutamyl Transferase Levels with Ascending Aortic Dilatation/Serum Gamma-glutamyl Transpherase Enzim Seviyesi ile Asendan Aort Dilatasyonu Arasindaki Iliski

Abstract

Increased serum gamma-glutamyl transferase levels (GGT) have been shown to directly promote oxidative stress. Previous studies have shown the relationship between the dilatation of the ascending aorta and oxidative stress. This study was designed to examine the relationship between serum GGT concentrations with dilatation of the ascending aorta. Ninety patients with ascending aortic dilatation and 90 age-sex-matched patients without aortic dilatation were included in the study. The patients were evaluated by a complete transthoracic echocardiographic examination including measurement of the aortic dimensions, where a diameter of 3.7 cm and above was accepted as ascending aortic dilatation. Serum GGT concentration was measured in all patients. In the group with aortic dilatation, HT frequency, serum uric acid, hs-CRP and GGT levels, the LV mass index, and the left atrial volume index were found to be higher than the control group. The logistic regression analysis showed that only HT frequency (OR:1.23, 95% CI 1.11-1.35, p value: 0.02), the LA volume index (OR: 1.34, 95% CI 1.21±1.4, p:0.005) and serum GGT levels (OR: 1.12, 95% CI 1.01±1.20, p:0.03) were found to be independent predictors. There was a significant correlation between serum GGT levels and ascending aortic diameter (r: 0.268, p<0.001). In the ROC curve analysis, AUC was 0.659 (0.580±0.738) for a 23.5 serum GGT cut-off value (64% sensitivity and 53% specificity). We found that serum GGT concentration was significantly associated with ascending aortic dilatation. Large epidemiological studies are required to correlate the findings from this study with clinical outcome.

Headnote

Abstract

Objective: Increased serum gamma-glutamyl transferase levels (GGT) have been shown to directly promote oxidative stress. Previous studies have shown the relationship between the dilatation of the ascending aorta and oxidative stress. This study was designed to examine the relationship between serum GGT concentrations with dilatation of the ascending aorta.

Materials and Methods: Ninety patients with ascending aortic dilatation and 90 age-sex-matched patients without aortic dilatation were included in the study. The patients were evaluated by a complete transthoracic echocardiographic examination including measurement of the aortic dimensions, where a diameter of 3.7 cm and above was accepted as ascending aortic dilatation. Serum GGT concentration was measured in all patients.

Results: In the group with aortic dilatation, HT frequency, serum uric acid, hs-CRP and GGT levels, the LV mass index, and the left atrial volume index were found to be higher than the control group. The logistic regression analysis showed that only HT frequency (OR:1.23, 95% CI 1.11-1.35, p value: 0.02), the LA volume index (OR: 1.34, 95% CI 1.21±1.4, p:0.005) and serum GGT levels (OR: 1.12, 95% CI 1.01±1.20, p:0.03) were found to be independent predictors. There was a significant correlation between serum GGT levels and ascending aortic diameter (r: 0.268, p<0.001). In the ROC curve analysis, AUC was 0.659 (0.580±0.738) for a 23.5 serum GGT cut-off value (64% sensitivity and 53% specificity).

Conclusion: We found that serum GGT concentration was significantly associated with ascending aortic dilatation. Large epidemiological studies are required to correlate the findings from this study with clinical outcome.

Key Words: Gamma-glutamyl transferase, aortic dilatation, oxidative stres

Özet

Amaç: Artmis serum gamma-glutamyl transpherase (GGT) seviyeleri- nin oksidatif stresi yansittigi gösterilmistir. Daha önce yapilan çalisma- larda aort dilatasyonu ile oksidatif stres arasindaki iliski gösterilmistir. Bu çalisma GGT konsantrasyonu ile asendan aort dilatasyonu arasin- daki iliskiyi arastirmak üzere dizayn edildi.

Gereç ve Yöntem: Bu çalismaya asendan aort dilatasyonu olan 90 hasta ve yas- cinsiyet olarak eslestirilmis aort dilatasyonu olmayan 90 hasta dahil edildi. Tüm hastalar aortik çap ölçümünü de içeren komple trastorasik ekokardiyografi ile degerlendirildi. 3,7 cam üzeri asendan aort dilatasyonu olarak kabul edildi. Tüm hastalarin serum GGT düzeyi çalisildi.

Bulgular: Aort dilatasyonu olan grupta hipertansiyon (HT) sikligi, se- rum ürik acid, hs-CRP ve GGT seviyeleri ve sol ventrikül kitle indeksi (LV mass-index), sol atriyal volum indeksi kontrol grubuna göre anlamli oranda daha yüksekti. Lojistik regresyon analizinde HT (OR: 1,23, %95 CI 1,11-1,35, p e: 0,02), sol atriyal volum indeksi (OR: 1,34, %95 CI 1,21- 1,4, p: 0,005) ve serum GGT seviyesi (OR: 1,12, %95 CI 1,01-1,20, p:0,03) bagimsiz prediktör olarak bulundu. Serum GGT seviyesi ile asendan aort diameter arasinda anlamli korelasyon bulundu (r: 0,268, p<0,001). ROC curve analizinde egri altinda kalan alan 0,659 (0,580-0,738), serum GGT seviyesi 23,5 alindiginda %64 duyarlilik ve %53 özgüllüge sahip oldugu bulundu.

Sonuç: Bu çalismada serum GGT düzeyi ile asendan aort dilatasyonu arasinda anlamli iliski oldugu gösterildi. Bu çalismanin klinil bulgulari genis epidemiyolojik çalismalar ile korele edilmesi gerekmektedir.

Anahtar Kelimeler: Gamma-glutamyl transferase, aortik dilatasyon, oksidatif stres

Introduction

Ascending aortic dilatation is not a rare condition, and several mechanisms have been shown to cause the disease, such as hemodynamic force, destructive remodeling of the extracellular matrix, familial predisposition and transmural inflammation [1-6]. Recent studies show that oxidative stress plays an important role in the development of aortic dilata- tion [1, 7, 8]. There is much evidence that shows the role of oxidative stress in the development of aortic dilatation. Inflammatory cells, lipid mediators, smooth muscle cells, growth factors and mechanical stretch produce reactive oxygen species, especially by the NADPH pathway, within the aortic local environment [1, 9] These factors are responsible for the regulation of matrix metalloproteins and for smooth muscle apoptosis, and changes in this regulation cause the balance between the generation and destruction of the aor- tic wall to shift [1].

Gamma Glutamyl Transferase (GGT) enzyme is commonly used as predictor for liver diseases such as hepatitis, fatty liver disease and alcohol consumption [1, 7, 9, 10]. Recent studies have shown that elevated serum GGT is significantly associated with increased risk of cardiovascular diseases (and with cardiovascular mortality) such as myocardial infarction, stroke, and complexity of coronary and carotid atherosclero- sis and heart failure [2-5].

Previous studies showed that an increase in serum GGT concentration can be used as a marker for increased oxida- tive stress [2, 3]. GGT plays a role as a protein catalyst in the degradation of glutathione at the physiological serum level, and glutathione is the major thiol antioxidant in the human body [2]. However, the relationship between serum GGT levels and ascending aortic dilatation has not been studied previously. This study was designed to examine the relation- ship between serum GGT concentrations and dilatation of the ascending aorta.

Materials and Methods

The ethics committee approved the study from the ethics committee of Ataturk Universty date 02.09.2013 and number B.30.2.ATA.0.01.00/173, and written consent was obtained from all patients. Ninety consecutive patients who were referred for transthoracic echocardiography in our institu- tion to evaluate chest pain, cardiac murmur, or shortness of breath and had aortic dilatation (>3.7 cm) were included study, along with age-sex matched 90 patient without aortic dilatation (≤3.7 cm).

Hypertension (HT) was defined as the use of antihyper- tensive agents or elevated blood pressure measurement of ≥140/90 mm Hg on at least three separate clinical visits. Diabetes mellitus (DM) was defined as having at least two fasting blood sugar measurements >126 mg/dL or using antidiabetic drugs. Body mass index values were calculated based on the height and weight of each patient. The exclu- sion criteria were alcohol consumption, cirrhosis, congestive heart failure, pericardial disease, renal failure (creatinine ≥1.5 mg/dL), liver disease (alanine aminotransferase, aspar- tate aminotransferase more than or equal to three times the upper limit normal), hemolytic disorders, concomitant inflammatory diseases such as infections and autoimmune disorders, osteoporosis, rheumatic heart disease, previous stroke, previous myocardial infarction, rheumatoid arthritis or other connective tissue diseases, neoplastic disease and documented coronary artery disease.

All participants underwent comprehensive two-dimen- sional, M-mode and Doppler echocardiographic examination performed by one experienced research echocardiographer, who was blinded to the biochemical data and used a com- mercially available echocardiograph equipped with a 2.5- and 3.5-MHz transducer (Philips ie33). 2-D and M-mode mea- surements of left ventricle (LV ) dimensions were performed. The LV mass index and the LA volume index were calcu- lated according to the American Society of Echocardiography guidelines.

Aortic valve morphology was examined in parasternal long- and short-axis views. The ascending aortic diameter was measured perpendicular to the long axis of the aorta with the use of the leading edge method in the parasternal long-axis view showing the largest aortic diameter, in accor- dance with the European Society of Echocardiography guide- lines [2]. All measurements were repeated up to five times and averaged. Ascending aortic dilatation was defined as an aortic diameter >3.7 cm. Only patients with ascending aortic dilatation were included in the study; patients with aortic root dilatation were excluded.

Blood Sample Collection

Blood samples were obtained after an overnight fasting period and were withdrawn from the antecubital vein. Serum GGT levels were measured by the enzymatic calorimetric test (Roche/Hitachi analyzer, Mannheim, Germany), and the nor- mal range of GGT activity was recognized as 7-49 U/l.

Statistical Analysis

All analyses were conducted using Statistical Package for the Social Sciences (SPSS) 11.5 (IBM SPSS, Chicago, IL, USA). Continuous variables were expressed as mean+s.d., and categorical variables were expressed as percentages. To compare the means of continuous variables between the groups categorized according to ascending aorta size, Student's t test or the Mann-Whitney U test was utilized. x2 analysis was used to compare the distribution of categorical variables. The Pearson correlation test was used to examine correlations between ascending aorta size and serum GGT concentration. To assess the influence of several baseline factors on the aortic diameter, multiple logistic regression analysis was performed. These variables were hypertension, uric acid, hs-CRP (high sensitivity C-reactive protein), GGT, the left ventricular (LV) mass index and the left atrial (LA) volume index with p<0.05 in the univariate analysis. Significance was defined at p<0.05.

Results

Ninety patients with ascending aortic dilatation and age-sex matched 90 patients without aortic dilatation were included in this study. The clinical, biochemical and echocar- diographic characteristics are summarized in Table 1.

In the group with aortic dilatation, HT frequency, serum uric acid, hs-CRP and GGT levels (Figure 1), the LV mass-index, and the left atrial volume index were found to be higher than in the control group (Table 1). The logistic regression analysis showed that only HT (OR: 1.23, 95% CI 1.11-1.35, p value: 0.02), the LA volume index (OR: 1.34, 95% CI 1.21-1.47, p value: 0.005) and serum GGT levels (OR: 1.12, 95% CI 1.01- 1.20, p value: 0.03) were independent predictors (Table 2). There was significant correlation between serum GGT levels and ascending aortic diameter (r: 0.268, p<0.001) (Figure 2). In the ROC curve analysis, AUC was 0.659 (0.580-0.738) for a 23.5 U/l serum GGT cut-off value (64% sensitivity and 53% specificity) (Figure 3).

Discussion

This is the first study to investigate the relationship between GGT activity and ascending aortic dilatation. In the ascending aortic dilatation group, hypertension, the LA volume index and serum GGT were found to be significantly higher than in the control group. Our results showed that increased GGT concentrations were independently associ- ated with an increased risk of ascending aortic dilatation.

Oxidative stress is a form of tissue damage occurring after the increased production and/or decreased destruction of reactive oxygen species. The balance between reactive oxygen species production and destruction depends on the levels of endogenous cellular antioxidants and antioxidant enzymes. The NADPH oxidase and xanthine oxidase path- ways are the two major systems responsible from vascular oxidative stress [2]. In the etiology of aortic dilatation, matrix metalloproteinases and reactive oxygen species play impor- tant roles [2]. Reactive oxygen and nitrogen species have been shown to regulate matrix metalloproteinase transcrip- tion and activation [2]. Matrix metalloproteinases are the most frequently detected proteolytic species in the develop- ment and establishment of aortic dilatation [2]. Oxidative stress also has been implicated in the pathogenesis of dis- eases ranging from hypertension to Parkinson's disease [4].

The mechanism of increasing GGT activity in cardiovascu- lar disease is currently unclear. However, oxidative stress and glutathione metabolism are thought to be potential mecha- nisms for GGT activity [4]. Additionally, serum GGT activity is negatively associated with several antioxidants such as beta carotene and vitamin C and positively associated with oxida- tive stress parameters. Therefore, higher concentrations of GGT may reflect increased oxidative stress. Ascending aortic dilatation involves several mechanisms, such as hemodynam- ic force, destructive remodeling of the extracellular matrix, familial predisposition and transmural inflammation [2, 6]. Recent studies show that oxidative stress plays an important role in the development of thoracic and abdominal aortic dilatation as well as progression [2, 8]. Similarly, Esen et al [1] showed that there was a positive correlation between an increase in oxidative stress and ascending aortic dilatation. They measured total antioxidant capacity and serum uric acid levels and showed significant correlation of uric acid concen- tration and antioxidant capacity with aortic dilatation. In our study, we showed a positive correlation between GGT, which is associated with an increase in oxidative stress, and aortic dilatation. Additionally, HT and the LA volume index were associated with aortic dilatation. In contrast to Esen et al. [1] in our study, the association of uric acid with aortic dilatation was significant in univariate analysis but not significant in multivariate analysis.

This study was the first to show that GGT levels are associ- ated with aortic dilatation. There is much evidence regarding the relationship between GGT levels and oxidative stress. Furthermore, it has been shown that the development and progression of aortic dilatation are associated with oxidative stress. Therefore, the relationship between serum GGT levels and aortic dilatation is important, as shown in our study. However, the relationship between GGT levels and the pro- gression of aortic dilatation could not be shown in this study because long-term monitoring of serum GGT levels and aor- tic diameter was not possible.

There are a couple of limitations to our study. First, the study population is small and narrowly defined. Second, aor- tic dilatation was detected and quantified by transthoracic echocardiography, and the data should be confirmed by CT imaging.

In conclusion our findings suggest that ascending aortic dilatation is associated with higher serum GGT levels, which may indicate the role of increased oxidative stress in ascend- ing aortic dilatation. Large-scale prospective, randomized studies are necessary to test the clinical value of this associa- tion in patients with ascending aortic dilatation and with high GGT levels.

Ethics Committee Approval: Ethics committee approval was received for this study from the ethics com- mittee of Ataturk University (02.09.2013 and number B.30.2.ATA.0.01.00/173).

Informed Consent: Written informed consent was obtained from patients who participated in this study.

Peer-review: Externally peer-reviewed.

Author Contributions: Concept - A.K., S.T.; Design - A.K., Z.Y.G.; Supervision - Y.K., O.E.; Funding - A.K., Y.K.; Materials - A.K., Y.K.P.; Data Collection and/or Processing - A.K., M.S.; Analysis and/or Interpretation - S.T., M.S.; Literature Review - AK., Y.K.; Writing - A.K., O.E.; Critical Review - Y.K., Z.Y.G.; Other - Y.K.P.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study has received no financial support.

References

References

1 . Esen AM, Akcakoyun M, Esen O, et al. Uric acid as a marker of oxidative stress in dilatation of the ascending aorta. American journal of hypertension 2011; 24: 149-54. [CrossRef]

2. Herron GS, Unemori E, Wong M, et al. Connective tissue protein- ases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 1991; 11: 1667-77. [CrossRef]

3. Freestone T, Turner RJ, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995; 15: 1145-51. [CrossRef]

4. Shah PK. Inflammation, metalloproteinases, and increased pro- teolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 1997; 96: 2115-7. [CrossRef]

5. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997; 95: 205-12. [CrossRef]

6. Karakaya O, Barutcu I, Esen AM, et al. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase-B) concentration and aortic root dilatation. Am J Hypertens 2006; 19: 361-5. [CrossRef]

7. Dubick MA, Keen CL, DiSilvestro RA, et al. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine 1999; 220: 39-45. [CrossRef]

8. Zhang J, Schmidt J, Ryschich E, et al. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J Vasc Surg 2003; 38: 360-7. [CrossRef]

9. Grote K, Flach I, Luchtefeld M, et al. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metal- loproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003; 92: e80-6. [CrossRef]

10. Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010; 13: 36-41. [CrossRef]

11. Aksakal E, Tanboga IH, Kurt M, et al. The relation of serum gam- ma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis 2012; 221: 596-601. [CrossRef]

12. Cayli M, Gur M, Kalkan GY, et al. Gamma glutamyl transferase activity : Herz 2013.

13. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxida- tive stress within the plaque. Circulation 2005; 112: 2078-80. [CrossRef]

14. Evangelista A, Flachskampf FA, Erbel R, et al. Echocardiography in aortic diseases: EAE recommendations for clinical practice. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2010; 11: 645-58. [CrossRef]

15. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355. [CrossRef]

1 6. Maiellaro-Rafferty K, Weiss D, Joseph G, et al. Catalase over- expression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am J Physiol Heart Circ Physiol 2011; 301: H355-62. [CrossRef]

17. Pincemail J, Defraigne JO, Cheramy-Bien JP, et al. On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm. Redox Rep 2012; 17: 139-44. [CrossRef]

18. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arteriosclerosis Thromb Vasc Biol 2011; 31: 3011-9. [CrossRef]

19. Guzik B, Sagan A, Ludew D, Mrowiecki W, Chwala M, et al. Mechanisms of oxidative stress in human aortic aneurysms- Association with clinical risk factors for atherosclerosis and disease severity. Int j Cardiol 2013; 168: 2389-96. [CrossRef]

20. Cafueri G, Parodi F, Pistorio A, et al. Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PloS one 2012; 7: e35312. [CrossRef ]